Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 375

1.

Pseudoinsulinoma in a white man with autoimmune hypoglycemia due to anti-insulin antibodies: value of the free C-Peptide assay.

Arzamendi AE, Rajamani U, Jialal I.

Am J Clin Pathol. 2014 Nov;142(5):689-93. doi: 10.1309/AJCPX56JQBJHUBGJ.

PMID:
25319986
[PubMed - in process]
2.

Increased Adipose Tissue Insulin Resistance in Metabolic Syndrome: Relationship to Circulating Adipokines.

Adams-Huet B, Devaraj S, Siegel D, Jialal I.

Metab Syndr Relat Disord. 2014 Aug 27. [Epub ahead of print]

PMID:
25162912
[PubMed - as supplied by publisher]
3.

Endotoxemia of Metabolic Syndrome: A Pivotal Mediator of Meta-Inflammation.

Jialal I, Rajamani U.

Metab Syndr Relat Disord. 2014 Aug 27. [Epub ahead of print]

PMID:
25162769
[PubMed - as supplied by publisher]
4.

Global toll-like receptor 4 knockout results in decreased renal inflammation, fibrosis and podocytopathy.

Jialal I, Major AM, Devaraj S.

J Diabetes Complications. 2014 Jul 12. pii: S1056-8727(14)00203-7. doi: 10.1016/j.jdiacomp.2014.07.003. [Epub ahead of print]

PMID:
25116192
[PubMed - as supplied by publisher]
5.

The role of dyslipidemia in diabetic retinopathy: A brighter focus?

Jialal I, Rajamani U, Siegel D.

J Diabetes Complications. 2014 Jul 11. pii: S1056-8727(14)00202-5. doi: 10.1016/j.jdiacomp.2014.07.002. [Epub ahead of print] No abstract available.

PMID:
25104239
[PubMed - as supplied by publisher]
6.

Circulating pathogen associated molecular pattern - binding proteins and High Mobility Group Box protein 1 in nascent metabolic syndrome: implications for cellular Toll-like receptor activity.

Jialal I, Rajamani U, Adams-Huet B, Kaur H.

Atherosclerosis. 2014 Sep;236(1):182-7. doi: 10.1016/j.atherosclerosis.2014.06.022. Epub 2014 Jul 17.

PMID:
25063948
[PubMed - in process]
7.

Measurement of low-density lipoprotein cholesterol in assessment and management of cardiovascular disease risk.

Jialal I, Remaley AT.

Clin Pharmacol Ther. 2014 Jul;96(1):20-2. doi: 10.1038/clpt.2014.69.

PMID:
24942398
[PubMed - indexed for MEDLINE]
8.

What is the role of the clinical laboratory in the new ACC/AHA guidelines for the treatment of blood cholesterol in adults?

Jialal I.

Am J Clin Pathol. 2014 Jun;141(6):772-3. doi: 10.1309/AJCPED9X7RNMYAEQ. No abstract available.

PMID:
24838319
[PubMed - indexed for MEDLINE]
9.

Use of HbA1c in the diagnosis of diabetes and prediabetes: sensitivity versus specificity.

Vikram NK, Jialal I.

Metab Syndr Relat Disord. 2014 Jun;12(5):255-7. doi: 10.1089/met.2014.1501. Epub 2014 Apr 9. No abstract available.

PMID:
24716577
[PubMed - in process]
10.

Relationship between retinol-binding protein-4/adiponectin and leptin/adiponectin ratios with insulin resistance and inflammation.

Jialal I, Adams-Huet B, Duong F, Smith G.

Metab Syndr Relat Disord. 2014 May;12(4):227-30. doi: 10.1089/met.2014.0013. Epub 2014 Mar 4.

PMID:
24593134
[PubMed - in process]
11.

No benefit of saxagliptin on cardiovascular outcomes in type 2 diabetes mellitus: potential explanations.

Jialal I, Dhindsa S.

Metab Syndr Relat Disord. 2014 Apr;12(3):157-8. doi: 10.1089/met.2014.1500. Epub 2014 Feb 12. No abstract available.

PMID:
24520851
[PubMed - in process]
12.

Comment on Lopes-Virella et al. Baseline markers of inflammation are associated with progression to macroalbuminuria in type 1 diabetic subjects. Diabetes care 2013;36:2317-2323.

Jialal I, Devaraj S.

Diabetes Care. 2014 May;37(5):e106-7. doi: 10.2337/dc13-2420. Epub 2014 Feb 4. No abstract available.

PMID:
24496802
[PubMed - in process]
13.

Potential anti-atherosclerotic effects of dipeptidyl peptidase-4 inhibitors in type 2 diabetes mellitus.

Dhindsa S, Jialal I.

Curr Diab Rep. 2014 Feb;14(2):463. doi: 10.1007/s11892-013-0463-z. Review.

PMID:
24390468
[PubMed - indexed for MEDLINE]
14.

Toll-like receptor status in obesity and metabolic syndrome: a translational perspective.

Jialal I, Kaur H, Devaraj S.

J Clin Endocrinol Metab. 2014 Jan;99(1):39-48. doi: 10.1210/jc.2013-3092. Epub 2013 Dec 20. Review.

PMID:
24187406
[PubMed - indexed for MEDLINE]
15.

Human C-reactive protein induces endothelial dysfunction in biobreeding diabetic rats.

Jialal I, Kaur H, Devaraj S, Smith G.

Diab Vasc Dis Res. 2013 Nov;10(6):550-3. doi: 10.1177/1479164113503971. Epub 2013 Sep 12.

PMID:
24028935
[PubMed - indexed for MEDLINE]
Free Article
16.

Increased expression of Fc-γ receptors on monocytes in patients with nascent metabolic syndrome.

Devaraj S, Chen X, Adams-Huet B, Jialal I.

J Clin Endocrinol Metab. 2013 Sep;98(9):E1510-5. doi: 10.1210/jc.2013-2112. Epub 2013 Jul 31.

PMID:
23902948
[PubMed - indexed for MEDLINE]
17.

A novel peptide inhibitor attenuates C-reactive protein's pro-inflammatory effects in-vivo.

Jialal I, Devaraj S, Smith G, Lam KS, Kumaresan PR.

Int J Cardiol. 2013 Oct 9;168(4):3909-12. doi: 10.1016/j.ijcard.2013.06.047. Epub 2013 Jul 19.

PMID:
23871616
[PubMed - in process]
18.

Amelioration in wound healing in diabetic toll-like receptor-4 knockout mice.

Dasu MR, Jialal I.

J Diabetes Complications. 2013 Sep-Oct;27(5):417-21. doi: 10.1016/j.jdiacomp.2013.05.002. Epub 2013 Jun 15.

PMID:
23773694
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Adipose tissue dysfunction in nascent metabolic syndrome.

Bremer AA, Jialal I.

J Obes. 2013;2013:393192. doi: 10.1155/2013/393192. Epub 2013 Apr 4. Review.

PMID:
23653857
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Modulation of endothelial progenitor cell number and function with n-3 polyunsaturated fatty acids.

Devaraj S, Chien A, Rao B, Chen X, Jialal I.

Atherosclerosis. 2013 May;228(1):94-7. doi: 10.1016/j.atherosclerosis.2013.02.036. Epub 2013 Mar 13.

PMID:
23528830
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk